Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research focused on Oncology and Biomarker, with related work in Downregulation and upregulation, Neuroblastoma RAS viral oncogene homolog, Identification (biology). Notable publications include 'Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis', 'Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients', and 'Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients'.
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis
Additional file 1 of Identification of DUSP4/6 overexpression as a potential rheostat to NRAS-induced hepatocarcinogenesis